Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.81
-0.16 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
5.76
-0.05 (-0.86%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Recursion Pharmaceuticals stock have an average target of 8.25, with a low estimate of 6.00 and a high estimate of 11. The average target predicts an increase of 42.00% from the current stock price of 5.81.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Recursion Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +3.27% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +89.33% | Feb 6, 2025 |
| Keybanc | Keybanc | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +72.12% | Jan 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +89.33% | Dec 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +89.33% | Nov 20, 2024 |
Financial Forecast
Revenue This Year
96.99M
from 58.84M
Increased by 64.84%
Revenue Next Year
151.28M
from 96.99M
Increased by 55.98%
EPS This Year
-1.74
from -1.69
EPS Next Year
-1.46
from -1.74
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 183.8M | 257.6M |
| Avg | 97.0M | 151.3M |
| Low | 45.2M | 64.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 212.3% | 165.6% |
| Avg | 64.8% | 56.0% |
| Low | -23.2% | -34.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.40 | -1.12 |
| Avg | -1.74 | -1.46 |
| Low | -2.84 | -1.76 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.